Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

354 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Carcinoma trial results

Active, Not Recruiting

Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma

NCT05784012

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +17 more
Locations
  • Institut Catalá d'Oncologia (ICO) BADALONA Badalona, Catalonia, Spain
  • Hospital Universitario Valle Hebron Barcelona, Catalonia, Spain
  • Hospital Clinic de Barcelona Barcelona, Catalonia, Spain
  • Institut Catalá d'Oncologia (ICO) Hospitalet L'Hospitalet de Llobregat, Catalonia, Spain
View Trial Details
Active, Not Recruiting

Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer

NCT02567422

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma of Unknown Primary, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

NCT06238479

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT06378177

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Anhui Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China
  • Fujian cancer hospital Fuzhou, Fujian, China
View all 16 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

NCT05172258

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
View all 20 locations
View Trial Details

Related conditions